pseudotumor cerebri

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:cerebral_venous_sinus_thrombosis
gptkb:Cushing's_syndrome
gptkbp:affects gptkb:Person
adults
gptkbp:associated_with gptkb:vitamin_A_toxicity
sleep apnea
polycystic ovary syndrome
thyroid disease
certain systemic diseases
gptkbp:can_lead_to gptkb:cerebral_venous_sinus_thrombosis
pseudopapilledema
gptkbp:caused_by increased intracranial pressure
gptkbp:complications vision loss
permanent blindness
gptkbp:current_use idiopathic intracranial hypertension
gptkbp:first_described_by in the 20th century
https://www.w3.org/2000/01/rdf-schema#label pseudotumor cerebri
gptkbp:improves corticosteroids
diuretics
acetazolamide
gptkbp:is_affected_by stress
hormonal changes
dehydration
certain medications
rapid weight gain
gptkbp:is_popular_in more common in women
gptkbp:is_tested_for visual field test
ophthalmologic examination
gptkbp:manager regular monitoring
pain management
vision assessments
gptkbp:premiered_on often occurs in young adults
gptkbp:requires ventriculoperitoneal shunt
optic nerve sheath fenestration
shunt placement
gptkbp:research_focus treatment efficacy
long-term outcomes
underlying mechanisms
gptkbp:risk_factor obesity
certain medications
female gender
gptkbp:social_responsibility MRI scan
lumbar puncture
gptkbp:symptoms headache
nausea
vision problems
tinnitus
gptkbp:title benign intracranial hypertension
gptkbp:treatment gptkb:hospital
weight loss
medications